Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is injected subcutaneously — into the fatty tissue just beneath the skin — at one of three licensed sites: the abdomen, the thigh, or the upper arm. Rotating between these areas each week reduces the chance of skin irritation and helps the medicine absorb consistently. As a prescription-only medicine, Mounjaro is prescribed following a clinical assessment; your prescriber and the Patient Information Leaflet are the definitive guides for your individual technique. This page covers the practical detail of each site so you arrive at your first injection with confidence rather than questions.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is approved for subcutaneous injection at three body areas. The abdomen is the most commonly chosen starting point: use the area at least 5 cm away from the navel to avoid the denser tissue around it. The front and side of either thigh works well too, particularly if you find it easier to see what you're doing. The outer upper arm is the third option, though most people find they need someone else to help reach it comfortably, it is perfectly valid to ask a partner or carer to assist.
There is no clinical hierarchy between the three sites. The NHS medicines page for tirzepatide confirms all three are suitable; what matters most is that you use one of the approved areas and rotate properly. If you want to explore the specifics of the arm injection in detail, there is a dedicated page on injecting Mounjaro in the upper arm that covers position and technique for that site.
Avoid the skin within 5 cm of any scar, stretch mark or skin condition. Injection sites around visible veins or areas of active inflammation should also be skipped.
Rotation is not optional. Injecting into the same small patch repeatedly causes lipohypertrophy, a hardening of fatty tissue that disrupts how the medicine is absorbed and can make injections uncomfortable. The rule is two-part: change the broad site each week (abdomen one week, thigh the next, for example) and also shift a few centimetres within whichever area you use.
A simple method is to think of the abdomen as a clock face. Move one or two positions around that clock each week rather than returning to the same spot. The same logic applies to the thigh: alternate between the left and right leg before repeating any exact spot. For a closer look at thigh injection positioning, the page on injecting Mounjaro in the leg goes through it in full.
A question our prescribers hear often: what if you have an upcoming holiday and want to inject early or late? Timing adjustments are a clinical decision, not something to manage by guessing. Your prescriber and the Patient Information Leaflet should be your first call, and if you are mid-treatment and have practical questions like this, the nume FAQs cover a range of timing scenarios. For completeness, the question of twice-weekly injections is answered separately, the short version is that Mounjaro is a once-weekly medicine and the schedule should not be altered without clinical guidance.
Clean the chosen spot with an alcohol swab and allow it to dry fully before the injection) wet skin increases the sting. You can use medical-grade alcohol swabs for this; they are sold separately if your supply runs low. Once dry, remove the pen cap and press the KwikPen firmly against the skin at a 90-degree angle until the skin indents slightly. Hold it flat, the pen is designed to be used this way, not angled like a dart. Press the injection button and hold for at least 10 seconds after you hear the click; lifting the pen too soon is the most common reason for incomplete dose delivery.
After the injection, do not rub the site. A small amount of redness or a minor weal is normal and usually fades within an hour or two. If you notice persistent swelling, hardness or skin changes at an injection site, mention it at your next clinical review.
Used needles and pens require safe disposal. A 1-litre sharps container keeps used components safely contained until your local pharmacy or council collection service can take them.
"Best" depends on your body composition, your comfort and whether you are injecting alone. People with more abdominal subcutaneous tissue often find that site easiest to manage, there is more to work with and it is easy to see. Those with less abdominal fat sometimes prefer the thigh, where the fatty layer can be more accessible. The detailed comparison of which site is best works through the individual factors if you want to think it through before your first pen.
There is also a broader question about whether Mounjaro is the right treatment for your situation in the first place. Cost context is part of that picture: Eli Lilly raised UK list prices significantly from September 2025, and the implications of that price change are worth understanding before you start. Once you have read the background on the Mounjaro treatment page, the next step is a free consultation where a GPhC-registered prescriber reviews your details and answers exactly these technique questions for your circumstances. How the injection process works end to end is covered separately if you would like a full walkthrough before booking. The Mounjaro Summary of Product Characteristics on the eMC is the authoritative reference for dosing, storage and administration detail.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.